Valuation Merck KGaA

Equities

Market Closed - Xetra Other stock markets 16:35:01 16/01/2026 GMT			5-day change	1st Jan Change
130.00 ^EUR	+0.85%		+1.33%	+6.04%

01-16	MERCK KGAA : JP Morgan reiterates its Buy rating	ZD
01-15	Pharma sector doubles down on AI amid hopes of slashing costs, timelines	RE

Data adjusted to current consolidation scope

Fiscal Period: December	2020	2021	2022	2023	2024	2025	2026	2027
Capitalization ¹	61,021	98,695	78,651	62,651	60,825	56,521	56,521	-
Change	-	61.74%	-20.31%	-20.34%	-2.91%	-7.08%	0%	-
Enterprise Value (EV) ¹	71,683	107,596	86,979	70,610	68,609	64,534	62,524	60,498
Change	-	50.1%	-19.16%	-18.82%	-2.83%	-5.94%	-3.12%	-3.24%
P/E ratio	30.7x	32.3x	23.6x	22.2x	21.9x	19.4x	19x	17.2x
PBR	3.59x	4.63x	3.03x	2.35x	2.03x	1.78x	1.68x	1.58x
PEG	-	0.6x	2.68x	-1.5x	-14.21x	3.84x	11.06x	1.6x
Capitalization / Revenue	3.48x	5.01x	3.54x	2.98x	2.88x	2.67x	2.63x	2.52x
EV / Revenue	4.09x	5.47x	3.91x	3.36x	3.24x	3.04x	2.91x	2.7x
EV / EBITDA	13.8x	17.6x	12.7x	12x	11.3x	10.6x	10.2x	9.32x
EV / EBIT	24x	25.7x	19.4x	19.6x	18.8x	16.7x	16.1x	13.9x
EV / FCF	34.7x	30.3x	31.9x	36.9x	23.8x	19.9x	21.4x	19.5x
FCF Yield	2.88%	3.3%	3.14%	2.71%	4.2%	5.01%	4.66%	5.13%
Dividend per Share ²	1.4	1.85	2.2	2.2	2.2	2.329	2.432	2.51
Rate of return	1%	0.81%	1.22%	1.53%	1.57%	1.79%	1.87%	1.93%
EPS ²	4.57	7.03	7.65	6.49	6.39	6.712	6.828	7.549
Distribution rate	30.6%	26.3%	28.8%	33.9%	34.4%	34.7%	35.6%	33.2%
Net sales ¹	17,534	19,687	22,232	20,993	21,156	21,195	21,483	22,388
EBITDA ¹	5,201	6,103	6,849	5,879	6,072	6,102	6,102	6,492
EBIT ¹	2,985	4,179	4,474	3,609	3,645	3,870	3,871	4,364
Net income ¹	1,987	3,055	3,326	2,824	2,777	2,843	2,866	3,246
Net Debt ¹	10,662	8,902	8,328	7,959	7,784	8,013	6,003	3,976
Reference price ²	140.35	227.00	180.90	144.10	139.90	130.00	130.00	130.00
Nbr of stocks (in thousands)	434,778	434,778	434,778	434,778	434,778	434,778	434,778	-
Announcement Date	04/03/21	03/03/22	02/03/23	07/03/24	06/03/25	-	-	-

¹EUR in Million²EUR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
MERCK KGAA	19.37x	3.04x	10.58x	1.79%	65.56B
KYOWA KIRIN CO., LTD.	24.11x	2.35x	10.47x	2.34%	8.5B
HALOZYME THERAPEUTICS, INC.	13.09x	6.78x	10.48x	-	8.37B
SK BIOPHARMACEUTICALS CO., LTD.	53.85x	12.84x	40.47x	-.--%	6.4B
YUHAN CORPORATION	65.64x	3.57x	41.09x	0.46%	5.47B
INDIVIOR PLC	18.49x	3.45x	9.92x	-.--%	4.06B
BETTA PHARMACEUTICALS CO., LTD.	36.95x	6.26x	20.62x	0.72%	3.01B
SUPERNUS PHARMACEUTICALS, INC.	-71.04x	-	-	-	2.87B
Average	20.06x	5.47x	20.52x	0.88%	13.03B
Weighted average by Cap.	21.78x	4.05x	14.36x	1.53%